Daniel Bernier, MS, RAC-US, MBA, is a global executive leader recognized for their dedication to regulatory affairs, quality assurance, and operational readiness. With extensive experience in various leadership roles at organizations such as Therapeutic Proteins Inc., Hospira, and Pfizer, they have demonstrated a commitment to executional excellence in the biopharmaceutical industry. Daniel has recently served as Sr. Director of Regulatory Affairs at POINT Biopharma and continues their education toward an MBA at Keller Graduate School of Management of DeVry University. Daniel holds a Master's degree from the Illinois Institute of Technology and a Bachelor's degree from Northern Illinois University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices